Literature DB >> 21209009

Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats.

Minolfa C Prieto1, Romer A González-Villalobos, Fady T Botros, Victoria L Martin, Javier Pagán, Ryousuke Satou, Lucienne S Lara, Yumei Feng, Fernanda B Fernandes, Hiroyuki Kobori, Dulce E Casarini, L Gabriel Navar.   

Abstract

Alterations in the balance between ANG II/ACE and ANG 1-7/ACE2 in ANG II-dependent hypertension could reduce the generation of ANG 1-7 and contribute further to increased intrarenal ANG II. Upregulation of collecting duct (CD) renin may lead to increased ANG II formation during ANG II-dependent hypertension, thus contributing to this imbalance. We measured ANG I, ANG II, and ANG 1-7 contents, angiotensin-converting enzyme (ACE) and ACE2 gene expression, and renin activity in the renal cortex and medulla in the clipped kidneys (CK) and nonclipped kidneys (NCK) of 2K1C rats. After 3 wk of unilateral renal clipping, systolic blood pressure and plasma renin activity increased in 2K1C rats (n = 11) compared with sham rats (n = 9). Renal medullary angiotensin peptide levels were increased in 2K1C rats [ANG I: (CK = 171 ± 4; NCK = 251 ± 8 vs. sham = 55 ± 3 pg/g protein; P < 0.05); ANG II: (CK = 558 ± 79; NCK = 328 ± 18 vs. sham = 94 ± 7 pg/g protein; P < 0.001)]; and ANG 1-7 levels decreased (CK = 18 ± 2; NCK = 19 ± 2 pg/g vs. sham = 63 ± 10 pg/g; P < 0.001). In renal medullas of both kidneys of 2K1C rats, ACE mRNA levels and activity increased but ACE2 decreased. In further studies, we compared renal ACE and ACE2 mRNA levels and their activities from chronic ANG II-infused (n = 6) and sham-operated rats (n = 5). Although the ACE mRNA levels did not differ between ANG II rats and sham rats, the ANG II rats exhibited greater ACE activity and reduced ACE2 mRNA levels and activity. Renal medullary renin activity was similar in the CK and NCK of 2K1C rats but higher compared with sham. Thus, the differential regulation of ACE and ACE2 along with the upregulation of CD renin in both the CK and NCK in 2K1C hypertensive rats indicates that they are independent of perfusion pressure and contribute to the altered content of intrarenal ANG II and ANG 1-7.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21209009      PMCID: PMC3064128          DOI: 10.1152/ajprenal.00383.2009

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  57 in total

1.  Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation.

Authors:  Carlos M Ferrario
Journal:  Hypertension       Date:  2005-12-19       Impact factor: 10.190

2.  Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.

Authors:  Javid Sadjadi; Gerald L Kramer; Chun-Hua Yu; M Burress Welborn; J Gregory Modrall
Journal:  J Surg Res       Date:  2005-06-29       Impact factor: 2.192

3.  KATP channel conductance of descending vasa recta pericytes.

Authors:  Chunhua Cao; Whaseon Lee-Kwon; Erik P Silldorff; Thomas L Pallone
Journal:  Am J Physiol Renal Physiol       Date:  2005-07-26

4.  Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes.

Authors:  Patricia E Gallagher; Mark C Chappell; Carlos M Ferrario; E Ann Tallant
Journal:  Am J Physiol Cell Physiol       Date:  2005-09-21       Impact factor: 4.249

5.  Effects of angiotensin-(1-7) blockade on renal function in rats with enhanced intrarenal Ang II activity.

Authors:  Marcela Bürgelová; Herbert J Kramer; Vladimír Teplan; Monika Thumová; Ludek Cervenka
Journal:  Kidney Int       Date:  2005-04       Impact factor: 10.612

6.  Developmental expression of ACE2 in the SHR kidney: a role in hypertension?

Authors:  C Tikellis; M E Cooper; K Bialkowski; C I Johnston; W C Burns; R A Lew; A I Smith; M C Thomas
Journal:  Kidney Int       Date:  2006-05-17       Impact factor: 10.612

7.  Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

Authors:  Carlos M Ferrario; Jewell Jessup; Mark C Chappell; David B Averill; K Bridget Brosnihan; E Ann Tallant; Debra I Diz; Patricia E Gallagher
Journal:  Circulation       Date:  2005-05-16       Impact factor: 29.690

8.  Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.

Authors:  Carlos M Ferrario; Jewell Jessup; Patricia E Gallagher; David B Averill; K Bridget Brosnihan; E Ann Tallant; Ronald D Smith; Mark C Chappell
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

9.  AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats.

Authors:  Minolfa C Prieto-Carrasquero; Hiroyuki Kobori; Yuri Ozawa; Astrid Gutiérrez; Dale Seth; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2005-05-03

10.  Escherichia coli lipopolysaccharide inhibits renin activity in human mesangial cells.

Authors:  W S Almeida; T T Maciel; G S Di Marco; D E Casarini; A H Campos; N Schor
Journal:  Kidney Int       Date:  2006-03       Impact factor: 10.612

View more
  35 in total

Review 1.  ACE and ACE2 in kidney disease.

Authors:  Sonoo Mizuiri; Yasushi Ohashi
Journal:  World J Nephrol       Date:  2015-02-06

2.  Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays.

Authors:  Kim Brint Pedersen; Srinivas Sriramula; Kavaljit H Chhabra; Huijing Xia; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-31       Impact factor: 3.619

Review 3.  Evolving concepts on regulation and function of renin in distal nephron.

Authors:  Minolfa C Prieto; Alexis A Gonzalez; L Gabriel Navar
Journal:  Pflugers Arch       Date:  2012-09-19       Impact factor: 3.657

4.  Combined Aliskiren and L-arginine treatment reverses renovascular hypertension in an animal model.

Authors:  Renata V Tiradentes; Cintia H Santuzzi; Erick Rg Claudio; Vinicius Mengal; Nyam F Silva; Henrique A F Neto; Nazaré S Bissoli; Glaucia R Abreu; Sonia A Gouvea
Journal:  Hypertens Res       Date:  2015-03-05       Impact factor: 3.872

Review 5.  ACE2 alterations in kidney disease.

Authors:  María José Soler; Jan Wysocki; Daniel Batlle
Journal:  Nephrol Dial Transplant       Date:  2013-08-16       Impact factor: 5.992

6.  Modulating Role of Ang1-7 in Control of Blood Pressure and Renal Function in AngII-infused Hypertensive Rats.

Authors:  Marta Kuczeriszka; Elzbieta Kompanowska-Jezierska; Janusz Sadowski; Minolfa C Prieto; L Gabriel Navar
Journal:  Am J Hypertens       Date:  2018-03-10       Impact factor: 2.689

7.  AT1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in ANG II-salt hypertension.

Authors:  Lucienne S Lara; Michael McCormack; Laura C Semprum-Prieto; Sylvia Shenouda; Dewan S A Majid; Hiroyuki Kobori; L Gabriel Navar; Minolfa C Prieto
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-07

Review 8.  Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?

Authors:  Ali Nehme; Kazem Zibara
Journal:  Hypertens Res       Date:  2017-07-06       Impact factor: 3.872

9.  Increased angiotensinogen expression, urinary angiotensinogen excretion, and tissue injury in nonclipped kidneys of two-kidney, one-clip hypertensive rats.

Authors:  Weijian Shao; Kayoko Miyata; Akemi Katsurada; Ryousuke Satou; Dale M Seth; Carla B Rosales; Minolfa C Prieto; Kenneth D Mitchell; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

Review 10.  Nonclassical renin-angiotensin system and renal function.

Authors:  Mark C Chappell
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.